Taro Pharmaceutical Industries Ltd. (NYSE:TARO) declared a dividend on Monday, November 5th, Fidelity reports. Stockholders of record on Tuesday, December 11th will be given a dividend of 12.81 per share on Friday, December 28th. The ex-dividend date is Monday, December 10th.
Shares of Taro Pharmaceutical Industries stock traded up $1.60 during trading hours on Wednesday, reaching $106.01. 66,248 shares of the company’s stock were exchanged, compared to its average volume of 44,333. Taro Pharmaceutical Industries has a fifty-two week low of $93.01 and a fifty-two week high of $121.23. The company has a market cap of $4.25 billion, a price-to-earnings ratio of 17.15 and a beta of 0.29.
Taro Pharmaceutical Industries (NYSE:TARO) last posted its quarterly earnings data on Monday, November 5th. The company reported $1.60 EPS for the quarter, missing the Zacks’ consensus estimate of $1.96 by ($0.36). Taro Pharmaceutical Industries had a return on equity of 11.99% and a net margin of 36.33%. The business had revenue of $158.97 million for the quarter, compared to analyst estimates of $167.40 million. Analysts expect that Taro Pharmaceutical Industries will post 7.65 earnings per share for the current year.
WARNING: “Taro Pharmaceutical Industries Ltd. Plans Dividend of $12.81 (TARO)” was published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://dakotafinancialnews.com/2018/12/05/taro-pharmaceutical-industries-ltd-plans-dividend-of-12-81-taro.html.
Taro Pharmaceutical Industries Company Profile
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories.
Recommended Story: How to use beta for portfolio diversification
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.